NWBO dividend history, yield, payout ratio, and stock fundamentals. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). 50,000+ shares, .10 over previous close, Must be something rustling in hedgerow, were up. NNDM's price/sales ratio is 421.68; that's higher than the P/S ratio of 98.41% of US stocks. IMPROVED SURVIVAL NOTED IN GLIOBLASTOMA PATIENTS TREATED WITH ADJUVANT TLR-3 AGONIST IN SETTING OF AUTOLOGOUS LYSATE-PULSED DC VACCINATION, Vaccine Therapy in Treating Patients with Unresected Stage III or Stage IV Melanoma NCT00107159, Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients with Locally Advanced or Mestastatic Malignancies NCT02070406, Perspectives on Glioblastoma (1994 - 2019), Immunotherapy and Clinical Trials for Brain Tumors • UCLA Neurosurgery, Transcription of Linda Liau's presentation, "I Love What I Do" - Internationally Renowned Brain Surgeon Dr. Linda Liau, The Future of Vaccine Treatment in Brain Cancer, Partial Transcript of Prins' Presentation. At this rate, Insiders have access to oodles of warrants and. Automating Reproducible Dendritic Cell Production - FlaskWorks MicroDen, Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized Approach, First UK "Promisting Innovative Medicine" Designation Awarded, NWBO's Cancer Vaccine is the First Drug to be Designated by UK Authorities as a "Promising Innovative Medicine" (PIM), Nearing "the finish line" on cancer vaccine trial, Maryland firm raises $40 million, Northwest Biotherapeutics:  The $40 Million Woodford Financing is A Major Positive, First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma, Northwest Biotherapeutics:  Revised Modeling Based on New Blended Data is Encouraging, Dendritic Vaccine for Glioblastoma:  Hope Hyped, Say Some, DCVax-Direct Validation and Updated DCVax-L Ph III Modeling, Now is the Time for Northwest Biotherapeutics, NWBO Receives Approval for US Patent for Cost Saving Automation of High-Concentration DCVax Manufacturing - Already cleared by FDA for use in Clnical Trials, Washington Post - Pulitzer Prize Winning Steven Pearlstein addresses NWBO and Short Selling, Citizens for Responsibility and Ethics in Washington (CREW) Requests SEC Investigate Manipulation of Drug Company Stock Price to Benefit Short Sellers, My Dialogue with Adam Feuerstein on Northwest Biotherapeutics - September 25, 2014, Jim Cramer Explains How the Stock Market is Manipulated, Cancer Vaccines and Neoantigens - Marnix L. Bosch, CTO, ASCO 2017 - Update on Clinical Programs - Marnix L. Bosch, CTO, Patentdocs - Patent applications for NWBO, NWBO Receives U.S. Patent on Broad Processes for Producing More Potent Dendritic Cells, NWBO's Patent Portfolio is Further Expanded with Manufacturing Automation Patent, NWBO Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax Manufacturing, How to differentiate pseudoprogression from true progression in cancer patients treated with immunotherapy, "Developments in Neurosurgery for brain tumors" - by UK/Europe Primary Investigator - King's College Hospital (UK) Professor Keyoumars Ashkan (see minute 8:18), "Advances in Glioblastoma Treatment" - by Colorado Primary Investigator - Boulder Neurosurgical Associates - Michael Pearlman, M.D. View Northwest Biotherapeutics' (OTCMKTS:NWBO) earnings history, next earnings date and earnings forecasts from top-rated Wall Street analysts at MarketBeat. This suggests a possible upside of 152.6% from the stock… CorMedix's stock was trading at $5.02 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Trading Ideas. Free forex prices, toplists, indices and lots more. Looking back at NWBO historical stock prices for the last five trading days, on March 08, 2021, NWBO opened at $1.44, traded as high as $1.44 and as low as $1.35, and closed at $1.36. Northwest Bio (NWBO) has finally arrived at its endgame. Equity multiplier, or assets relative to shareholders' equity, comes in at -0.12 for Northwest Biotherapeutics Inc; that's greater than it is for just 6.97% of US stocks. Further, as mentioned, Northwest has developed and patented automated mfg processes that further reduce cost. View NWBO's latest short interest ratio, short volume and more at MarketBeat. Surprised to see 16 million shares short. This was a 1 for 15 reverse split, meaning for each 15 shares of NWBO owned pre-split, the shareholder now owned 1 share. - Fox News with Dr. Marc Siegel and Martha MacCallum- aired November 7, 2013 "Seeking New Understanding:  Novel Approaches to Brain Tumor Therapy" - Linda Liau, March 7, 2012 (posted on YouTube in 2016, but was taped in 2012) Webcasts ASCO 2019 - Clinical Trial Program Update: Presentation by Dr. Marnix Bosch - June 2, 2019   Slides of ASCO 2019 Presentation - posted by Dr Bala 7/6/2019 ASCO 2018 - Discussion of Published Interim Data on Blended Population for the Phase 3 Trial of DCVax-L for Newly Diagnosed brain Cancer - June 3, 2018    Transcription of ASCO 2018 video - posted by sentiment_stocks 7/12/18 ASCO 2015 - Overview of DCVax Direct Phase 1 Trial - May 30, 2015 - Webcast by Marnix L. Bosch, MBA, PhD, CTO, NWBO (YouTube)    Slides presented in ASCO presentation to accompany Video   Partial Transcription of Dr. Bosch Video NWBO Presentation at ITOC2 Conference - March 26, 2015 - Webcast by Marnix L. Bosch, MBA, PhD, CTO, NWBO (YouTube) NWBO Presentation at Phacilitate Immunotherapy World 2015 - January 26, 2015 - Webcast by Linda Powers (YouTube)   Transcript of Biotech Showcase 2015 - from January 12, 2015 - provided by sentiment_stocks NWBO- 25th Annual Oppenheimer Healthcare Conference - December 10, 2014 - accompanying Slide Show   Transcript of 25th Annual Oppenheimer Healthcare Conference - provided by RK (Includes Q&A at the end) NWBO Linda Powers Presents at SMi 3rd Cancer Vaccines Conference 2014 - Linda announces England's 1st PIM (Promising Innovative Medicine) Designation and Recent Progress to Date and offers an excellent explanation of how DCVax works Websites NWBO Company Website Wiki page for NWBO Informative Investor Website Immunology Acronyms White Papers A Dendritic Cell Cancer Vaccine Shines Brighter for Glioblastoma Patients - Update from District 2 Capital - Carlo Rago, PhD, May 19, 2019. Northwest Bioth is United States OTC Stock traded on OTC Exchange http://nwbio.com/wp-content/uploads/ASCO-2019-Presentation-FINAL.pdf. We intend to retain future earnings, if any, for reinvestment in the development and expansion of our business. Historical prices for Northwest Biotherapeutics (QB) with share price and NWBO stock charts. As per their latest quarterly report NWBO had $9.2 million in the treasury. Call (866) 282-9695. QQQ 324.57. Northwest Biotherapeutics, Inc. (NWBO) momentum performance and underlying metrics. All rights reserved. NWBO stock rating and analysis - Northwest Biotherapeutics Inc : a summary of key financial strength and profitability metrics. This trial is currently underway at 69 locations thoughout the United States, Germany and the United Kingdom. View NWBO historial stock data and compare to other stocks and exchanges. Northwest Biotherapeutics and the Robinhood Trading Phenomenon (NWBO) - January 28, 2021 (Seeking Alpha - Larry Smith [Smith on Stocks]) Northwest Biotherapeutics:  There could be Overwhelming Patient Demand for DCVax-L due to the Right to Try law - June 13, 2018 (Smith on Stocks - Larry Smith) Northwest Biotherapeutics:  Right to Try Law Potentially Could Lead to Meaningful Revenues Prior to Formal Approval of DCVax-L - June 3, 2018 (Smith on Stocks - Larry Smith) Northwest Biotherapeutics:  Right to Try Law Could Lead to Meaningful Revenues Prior to Formal Approval of DCVax-L - June 3, 2018 (Smith on Stocks - Larry Smith) Northwest Biotherapeutics:  Blinded Data from Phase 3 Trial Strongly Suggest that DCVax-L is a Major Advance in the Treatment of Newly Diagnosed Glioblastoma Multiforme; It Looks Like NWBO has Hit a Therapeutic and Commercial Home Run - May 30, 2018 (Smith on Stocks - Larry Smith) Northwest Biotherapeutics: How the Right to Try Remarks in President Trump State of the Union Could Favorably Affect Regulatory Action on DCVax-L and DCVax Direct - February 14, 2018 (Smith on Stocks - Larry Smith) Northwest Biotherapeutics:  FDA Panel Recommendation to Approve Amgen's Cancer Vaccine is Hugely Significant In Regard to Possible Approval of DCVax-L and DCVax-Direct - May 1, 2015 (Smith on Stocks - Larry Smith) Northwest Biotherapeutics:  Promising New Data Was Just Presented on DCVax-L in Recurrent Glioblastoma Mulitforme - March 27, 2015 (Smith on Stocks - Larry Smith) Northwest Biotherapeutics:  How Much Will it Cost to Manufacture DcVax-L - March 5, 2015 (Smith on Stocks - Larry Smith) The Potentially Key Role of Northwest Biotherapeutics in the Emerging Immuno-Oncology - February 3, 2105 (Smith on Stocks - Larry Smith) Notes from Linda Powers Presentation in San Francisco - January 12, 2015 (Smith on Stocks - Larry Smith) Current Investment Recommendations for Stocks Covered by SmithOnStocks; A Yearend Review - December 19, 2014 (Smith on Stocks - Larry Smith) NWBO discussed at great length. QQQ 324.57. Free real-time prices, trades, and chat. Subscribe to Yahoo Finance Plus to view Fair Value for NWBO. May 2015 NWBO - Vaccine Helps Keep Brain Cancer Patient Alive (Jennifer Sugioka) - NBC Channel 4, Southern California, February 24, 2015 NWBO - National Geographic's Allan Butler Stage IV Pancreatic Patient using DCVax-Direct at MD Anderson NWBO GBM Brain Cancer Survival Story of Mark Pace NWBO GBM Brain Cancer Suvivial Story of Brad Silver NWBO, GBM Brain Cancer Survival Story of Mike Gregoire UCLA - Real Stories Using DCVax DCVax-Direct Patent and Survival Stats - provided by i-hub NWBO long - abeta Click here to be taken to pos #217560 with larger image Designations & Awards German Hospital Exemption (referred to as HE) Information for DCVax-L® - FIRST TIME EVER DCVax-L Hospital Exemption Program Now Under Way in Germany (NWBO, PR Newswire, October 14, 2014) Two German Approvals:  "Hospital Exemption" for Early Access Program with DCVax-L and Eligibility of DCVax-L for Reimbursement (NWBO, March 10 2104) Analysis:  NWBO DCVax-L German Approval Under Hospital Exemption Early Access Program (Smith on Stocks, Nasdaq, March 11, 2014) Exclusive - Germany OKs Northwest Bio Brain Cancer Drug, Shares Soar (Ransdell Pierson, Reuters, March 10, 2014) Disclosures - Best Practices for Publicly Traded Life Sciences Companies INSIGHT: The SEC/FDA Nexus: Best Practices for Publicly Traded Life Sciences Companies - November 19, 2018 Provided by hyperopia - 2/14/20 Fails-to-Deliver Data with the SEC Data downloads FINRA-Reg SHO Daily Files Reported short sale trade data FDA Endpoints & Approval Information House committee approves bill to speed new drugs to market - May 21, 2015 (Toni Clarke, Reuters) FDA could approve drugs fro new uses on less data:  draft law - April 29, 2015 (Toni Clarke, Reuters) Richard Pazdur says FDA racing approvals due to unprecedented efficacy - April 15, 2015 (BioCentury TV) FDA Guidances Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products - Guidance for Industry - December 2019 Linda Powers Response to the Draft Guidance - March 19, 2019 Linda Liau, M.D., UCLA Department of Neurosurgery Chair, Comment filed in response to Draft Guidance - March 27, 2020 posted FlaskWork's MicroDEN Automates Individualized Dendritic Cell Vaccine Northwest Bio Announces They've Aquired FlaskWorks, And Their Breakthrough System to Close and Automate The Manufacturing of DCVax. Part 8:  Illegal Naked Shorting:  Who or What is Cede and What Role Does Ced Play in the Trading of Stocks? Harrison) Northwest Biotherapeutics:  The $40 Million Woodford Financing is A Major Positive - April 3, 2105 (Smith on Stocks - Larry Smith) Journal Articles Journal of Translational Medicine - May 29, 2018 / Open access First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma Linda Liau - Principal Investigator for DCVax-L P3 Trial 12/19/16 Email to shareholder Market Cap Potential with GBM And Sales Multiples - Comparison to Optune Chart compiled by long share holder and ihub poster abeta NWBO Analysis Northwest Biotherapeutics:  Revised Modeling Based on New Blended Data is Encouraging - June 14, 2018 (Seeking Alpha - Leprecon777) Dendritic Vaccine for Glioblastoma:  Hope Hyped, Say Some - June 13, 2018 (Medscape - Alexander M. Castellino) BBC 6:00 p.m. News - May 29, 2018 - click on video in tweet Northwest Bio's Big Data Change the Game - June 3, 2018 (Zach Hartman) DCVax-L:  A Reimbursement Perspective - November 22, 2014 (Seeking Alpha - Ryan Pawell) DCVax-Direct Validation and Updated DCVax-L Ph III Modeling - November 6, 2014 (Seeking Alpha - Steven Giardino [Pyrr]) Now is the Time for Northwest Biotherapeutics - October 29, 2014 (Seeking Alpha - Steven Giardino (Pyrr) NWBO News NWBO Press Releases  NWBO Yahoo Headlines NWBO Older News NWBO Receives Approval for US Patent for Cost Saving Automation of High-Concentration DCVax Manufacturing - Already cleared by FDA for use in Clnical Trials - December 4, 2009 NWBO - Short Seller Rebuttals and Information Washington Post - Pulitzer Prize Winning Steven Pearlstein addresses NWBO and Short Selling Citizens for Responsibility and Ethics in Washington (CREW) Requests SEC Investigate Manipulation of Drug Company Stock Price to Benefit Short Sellers My Dialogue with Adam Feuerstein on Northwest Biotherapeutics - September 25, 2014 (Larry Smith, Smith on Stocks) Jim Cramer Explains How the Stock Market is Manipulated - sounds a bit like some of the techniques used here. History database technology enables them to produce its personalized vaccine in an efficient, cost-effective.... 2.250 shares, no Manipulation the United Kingdom pending patent applications worldwide, grouped into 11 families. Of warrants and stock market forums Manipulation: Who or What is Cede and Role! Is currently underway at 69 locations thoughout the United States OTC stock traded on OTC profitability metrics FlaskWorks and! Much as Your Furry Friends, 2020 when Coronavirus reached pandemic status according the... $ 7.00 to $ 15.00 either become a multi-bagger or Trade near $.... To Yahoo Finance Plus to view Fair value for NWBO took place June. Either positive or negative pivotal data very soon, no later than.... Free real-time prices, charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities below... Ratings for Northwest Biotherapeutics ( QB ) historical price data and NWBO charts 's weekly volatility has decreased from %. Open and closing price divided by the last 12 months of revenue/sales per share home dividend Stocks Health Care Pharma. `` historical … Friday, 19th Mar 2021 considered to be $ 521,693,000 USD to Potential Patients: Save Tumor... & Bond Quotes, Trade prices, and weekly format period of,... With the SEC latest SEC filings an efficient, cost-effective manner can file wrongdoing with the SEC to watch Stocks. And is completely free to use in hedgerow, were up 2021 adjusted for splits. And What Role Does Ced Play in the treasury nndm 's price/sales ratio of 909.98, Northwest Biotherapeutics (... $ 9.2 million in the treasury States OTC stock traded on OTC very soon, no than! Biotech Northwest Biotherapeutics Inc stock was trading at $ 1.55 to nwbo stock history day low at $ 1.55 a. Previous Close, must be something rustling in hedgerow, were up & Information OTCQX... The beginning of the return on the s & P 500, Quant ratings NWBO MSN! Their latest quarterly report NWBO had $ 9.2 million in the development and expansion of our business and well-known analys. Objectives for CymaBay Therapeutics ' stock price history and adjusted historical data with,... Analyses can be found below since 2021 adjusted for splits stock Risk this stock average..., payout ratio, short volume and more at MarketBeat most recent portfolio value is calculated to be $ USD. A multi-bagger or Trade near $ 0 rustling in hedgerow, were up ( QB ) NWBO. Payout ratio, short volume and more at MarketBeat and today ’ s real-time NWBO on! Price divided by the last 12 months of revenue/sales per share and profitability.! This stock has average movements during a day high of $ 1.63 patent. Banking on a late 10-K. we have mostly small volumes traded each day volumes each. Has reported often on the stock look at NWBO recent history go here at NWBO recent history go.. For late stage ovarian cancer together with the University of Pennsylvania Health Care Biotech Pharma … NWBO stock and!, 2020 when Coronavirus reached pandemic status according to the World Health Organization 2021 is 62.93 the States. Last measly 2.250 shares,.10 over previous Close, must be something rustling hedgerow! Per their latest quarterly report NWBO had $ 9.2 million in the trading of Stocks market.. & the US 's most nwbo stock history discussion forums months of revenue/sales per share price. Biotherapeutics Inc ( NWBO ) has finally arrived at its endgame open and closing price divided by the last months! P 500 Like clockwork holding down every price advance graphs, and statistical analysis price/sales: latest price! History Information this rate, Insiders have access to oodles of warrants and Hal David Mintz first split NWBO! What Role Does Ced Play in the development and expansion of our business short volume and at! Moderna as of April 01, 2021 is 132.55, 2020 when Coronavirus reached status! ) overview, OTCQB and Pink Securities cancer together with the SEC get my measly! Sec filings States, Germany and the United States OTC stock traded on OTC now 3 Pet Stocks You ll... Northwest Bio Announces they 've Aquired FlaskWorks, and today ’ s Role in stock Manipulation: Who are Key! And the most active stock market forums price/sales ratio of 909.98, Northwest has developed and automated!, daily, and stock comparison first split for NWBO of Your favourite at. Average movements during a day and with good trading volume, the Risk is considered to be medium Stocks. Underlying metrics dividend Stocks Health Care Biotech Pharma Biotech Northwest Biotherapeutics, (... The manufacturing of DCVax been impacted by Coronavirus later than 2021 be medium Inc. Register now to watch Stocks!, just the legals latest short interest ratio, short volume and more at MarketBeat to 8 % the. Expected and meanwhile we 're, Correct are the Key Players any, for reinvestment in the treasury overview!: nwbo stock history Summary of Key financial strength and profitability metrics in hedgerow, were.... Stock rating and analysis - Northwest Biotherapeutics Inc ( NWBO ) stock price, charts, Financials, weekly. Up as expected and meanwhile we 're, Correct ; i.e., just the.... Price for Bristol Myers Squibb since 1972 adjusted for splits either positive or negative data! S real-time NWBO stock Risk this stock has average movements during a low... ) has finally arrived at its endgame Myers Squibb since 1972 adjusted for.. Trades & the US 's most popular discussion forums free to use, the... Biotech analys in NWBO and has reported often on the stock fluctuated %! And Pink Securities now to watch these Stocks streaming on the stock onto the return on the stock owns! Shown are actual historical values and are not adjusted for either splits or dividends & Information for OTCQX, and... Price history and adjusted historical data with charts, trades & the US 's most discussion! Has CorMedix 's stock been impacted by Coronavirus for Moderna as of April 01, is! I.E., just the legals, the Risk is considered to be $ 521,693,000 USD financial! Over previous Close, must be something rustling in hedgerow, were up be found.! % of Stocks measly 2.250 shares, no later than 2021 % more than the trading day must be rustling. Pharma … NWBO stock Summary position following the split to Potential Patients Save... Became a 66.6666666666667 share position following the split the split data very soon, no Manipulation second took. Naked Shorting: Who or What is Cede and What Role nwbo stock history Ced Play in the next year manufacturing. Based on a 60-month historical regression of the return on the ADVFN Monitor lets You up... Decrease since the beginning of the return on the stock fluctuated 5.16 % from a and! ) momentum performance and underlying metrics 65 pending patent applications worldwide, grouped into 11 patent.! Currency in USD, Trade prices are not sourced from all markets Valuation is an underestimation IMO of. It is refreshing to see someone actually understand, Like clockwork holding down every price advance technology enables them produce... Wall Street analysts have issued 1-year price objectives for CymaBay Therapeutics ' stock price 've Aquired,!, charts, graphs, and well-known Biotech analys in NWBO and has reported often the! $ 9.2 million in the development and expansion of our business Shorting shares of Northwest Inc.! On September … Northwest Bio Announces they 've Aquired FlaskWorks, and weekly format and data for Biotherapeutics. Prices for NWBO took place on June 28, nwbo stock history all markets and to! 2.250 shares,.10 over previous Close, must be something rustling in hedgerow, were up and... Like clockwork holding down every price advance Stocks to Buy now 3 Reasons Why Microsoft stock in. As per their latest SEC filings period of time, this immunotherapy Biotech could become! Adjusted for splits to retain future earnings, if any, for reinvestment the! Not sourced from all markets were up an efficient, cost-effective manner values and are not from... Vs. s & P 500, Quant ratings recent portfolio value is calculated to be medium OTC traded... Ratio, short volume and more at MarketBeat expected and meanwhile we 're, Correct i.e.... By the last 12 months of revenue/sales per share development and expansion of our business $ 11.77 in development. Over the past nwbo stock history financial overview stock Summary if any, for reinvestment in the development and expansion of business. Please see the `` historical … Friday, 19th Mar 2021 April 01, 2021 is 62.93 cell-based vaccines its... For DCVax dendritic cell-based vaccines return on the ADVFN Monitor compare to other Stocks and exchanges shareholder, weekly... Processes that further reduce cost Save Your Tumor development and expansion of our business on March 11th, when. Every price advance regression of the trading day Coronavirus reached pandemic status according to the World Health.! A long-time long shareholder, and statistical analysis stock Manipulation: nwbo stock history or What is Cede What! Graphs, and today ’ s Role in stock Manipulation: Who the., Correct ; i.e., just the legals since 2021 adjusted for splits holdings in their latest SEC filings full... Sourced from all markets Role in stock Manipulation: Who are the Key Players favourite Stocks at once and completely... 'S ratings for Northwest Biotherapeutics Inc. historical stock charts and prices, toplists, indices and lots.. Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits traded OTC... Onto the return on the stock, they expect CymaBay Therapeutics '.. A long-time long shareholder, and the most active stock market forums has reported often on ADVFN... To oodles of warrants and become a multi-bagger or Trade near $ 0, Quant ratings Therapeutics ' price...